Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer

European Journal of Surgical Oncology

Volumn 32, Issue 7, 2006, Pages 707-709

  McCarthy, K ^a   Bustin, S A ^a   Ogunkolade, B ^a   Khalaf, S ^a   Laban, C A ^a   McVittie, C J ^a   Carpenter, R ^a   Jenkins, P J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclo oxygenase (COX); Human epidermal growth factor receptor 2 (HER 2); Non steroidal anti inflammatory drug (NSAID); Oestrogen receptor (ER); Progesterone receptor (PgR)

Indexed keywords

CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSCRIPTION; TUMOR VASCULARIZATION; TUMOR VOLUME;

BREAST; BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 33747779671     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.02.024     Document Type: Article

References (23)

1. Gupta R.A., and DuBois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1 1 (2001 October) 11-21
2. Hull M.A. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?. Eur J Cancer 41 13 (2005 September) 1854-1863
3. Egan K.M., Stampfer M.J., Giovannucci E., Rosner B.A., and Colditz G.A. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88 14 (1996 July 17) 988-993
4. Paganini-Hill A., Chao A., Ross R.K., and Henderson B.E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 299 6710 (1989 November 18) 1247-1250
5. Thun M.J., Namboodiri M.M., and Heath Jr. C.W. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325 23 (1991 December 5) 1593-1596
6. Harris R.E., Namboodiri K.K., and Farrar W.B. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7 2 (1996 March) 203-205
7. Friedman G.D., and Ury H.K. Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst 65 4 (1980 October) 723-733
8. Schreinemachers D.M., and Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5 2 (1994 March) 138-146
9. Sharpe C.R., Collet J.P., McNutt M., Belzile E., Boivin J.F., and Hanley J.A. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83 1 (2000 July) 112-120
10. Khuder S.A., and Mutgi A.B. Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84 9 (2001 May 4) 1188-1192
11. Robertson F.M., Parrett M.L., Joarder F.S., Ross M., Abou-Issa H.M., Alshafie G., et al. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 122 1-2 (1998 January 9) 165-175
12. Lala P.K., Al Mutter N., and Orucevic A. Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer 73 3 (1997 November 4) 371-380
13. Howe L.R., Subbaramaiah K., Brown A.M., and Dannenberg A.J. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 8 2 (2001 June) 97-114
14. Brueggemeier R.W., Quinn A.L., Parrett M.L., Joarder F.S., Harris R.E., and Robertson F.M. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett 140 1-2 (1999 June 1) 27-35
15. Ristimaki A., Sivula A., Lundin J., Lundin M., Salminen T., Haglund C., et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62 3 (2002 February 1) 632-635
16. Hwang D., Scollard D., Byrne J., and Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90 6 (1998 March 18) 455-460
17. Bennett A., Berstock D.A., Carroll M.A., Stamford I.F., and Wilson A.J. Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins. Adv Prostaglandin Thromboxane Leukot Res 12 (1983) 299-302
18. Half E., Tang X.M., Gwyn K., Sahin A., Wathen K., and Sinicrope F.A. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62 6 (2002 March 15) 1676-1681
19. Singh-Ranger G., Kirkpatrick K.L., Clark G.M., and Mokbel K. Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Curr Med Res Opin 19 2 (2003) 131-134
20. Costa C., Soares R., Reis-Filho J.S., Leitao D., Amendoeira I., and Schmitt F.C. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55 6 (2002 June) 429-434
21. Soslow R.A., Dannenberg A.J., Rush D., Woerner B.M., Khan K.N., Masferrer J., et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89 12 (2000 December 15) 2637-2645
22. Gilhooly E.M., and Rose D.P. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol 15 2 (1999 August) 267-270
23. Arpino G., Green S.J., Allred D.C., Lew D., Martino S., Osborne C.K., et al. HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. Clin Cancer Res 10 17 (2004 September 1) 5670-5676